{{Rsnum
|rsid=10771399
|Chromosome=12
|position=28155080
|Orientation=minus
|GMAF=0.1019
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 70.8 | 26.2 | 3.1
| HCB | 57.8 | 42.2 | 0.0
| JPT | 56.8 | 36.4 | 6.8
| YRI | 95.2 | 4.8 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 57.8 | 42.2 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{PMID Auto
|PMID=22348646
|Title=Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
|OA=1
}}

{{PMID Auto
|PMID=22267197
|Title=Genome-wide association analysis identifies three new breast cancer susceptibility loci
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23544013
  |Trait=Breast Cancer in BRCA1 mutation carriers
  |Title=Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
  |RiskAllele=A
  |Pval=8E-6
  |OR=1.18
  |ORtxt=[1.1-1.27]
  |OA=1
}}

{{PMID Auto GWAS
  |PMID=23535733
  |Trait=Breast cancer
  |Title=Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
  |RiskAllele=T
  |Pval=2E-12
  |OR=1.20
  |ORtxt=[1.15-1.27]
  |OA=1
}}

{{PMID Auto GWAS
  |PMID=23535729
  |Trait=Breast cancer
  |Title=Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
  |RiskAllele=A
  |Pval=8E-31
  |OR=1.16
  |ORtxt=[1.14-1.2]
  |OA=1
}}

{{PMID Auto GWAS
  |PMID=24325915
  |Trait=Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)
  |Title=Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.
  |RiskAllele=G
  |Pval=2E-8
  |OR=1.39
  |ORtxt=[1.25-1.56]
  }}
{{on chip | FTDNA}}